Employees work on the production line of CoronaVac, Sinovac Biotech’s vaccine against COVID-19 at the Butantan biomedical production center, in Sao Paulo, Brazil, on Jan. 14, 2021. The National Anti-Corruption Bureau of Ukraine (NABU) is investigating possible foul play in Ukraine’s procurement of China’s Sinovac Biotech vaccine at inflated prices. (Photo by NELSON ALMEIDA / AFP)
Photo by AFP
The National Anti-Corruption Bureau of Ukraine (NABU) is investigating possible foul play in Ukraine’s procurement of Chinese COVID-19 vaccine at inflated prices.
Despite the presence of much cheaper and more effective alternatives, the Ministry of Health chose to buy 1.9 million doses from China’s Sinovac Biotech through a Ukrainian intermediary under unclear circumstances. The ministry later made deals to buy from other manufacturers as well.
